Top

Published in:

Open Access 01-11-2010 | Review

Imaging of endometrial and cervical cancer

Authors: Shilpa Patel, Sidath H. Liyanage, Anju Sahdev, Andrea G. Rockall, Rodney H. Reznek

Published in: Insights into Imaging | Issue 5-6/2010

Abstract

In this article we review the ever increasing role of imaging in endometrial and cervical cancer. Magnetic resonance imaging (MRI) has emerged as the most widely used technique in the management of women with gynaecological cancer. In endometrial cancer, MRI is reliable in identifying myometrial and cervical invasion and extra-uterine disease, thereby informing preoperative surgical planning. In cervical cancer, MRI plays a crucial role in distinguishing early from advanced disease, thereby stratifying patients for surgery and chemoradiation. MRI is also valuable in assessing proximal extension of cervical tumours in young women with early stage disease for feasibility of fertility preserving surgery. In both cancers, imaging is used for diagnosing nodal metastases, detection of recurrence, and dealing with complications of both the disease and treatment.

Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366(9484):491–505PubMed

Kitchener HC, Trimble EL (2009) Endometrial cancer state of the science meeting. Int J Gynecol Cancer 19(1):134–140PubMed

Cancer Research UK. CancerStats. Available via http://info.cancerresearchuk.org/cancerstats/. Accessed 4 July 2010

Rose PG (1996) Endometrial carcinoma. N Engl J Med 335(9):640–649PubMed

Polin SA, Ascher SM (2008) The effect of tamoxifen on the genital tract. Cancer Imaging 8:135–145PubMedPubMedCentral

Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, Weiss NS (2008) Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am J Epidemiol 168(6):563–570PubMedPubMedCentral

Minagawa Y, Sato S, Ito M, Onohara Y, Nakamoto S, Kigawa J (2005) Transvaginal ultrasonography and endometrial cytology as a diagnostic schema for endometrial cancer. Gynecol Obstet Investig 59(3):149–154

Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375(9721):1165–1172PubMed

Kosary CL (1994) FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 10(1):31–46PubMed

10.

Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60(8 Suppl):2035–2041PubMed

11.

Sahdev A, Reznek RH (2008) Magnetic resonance imaging of endometrial and cervical cancer. Ann NY Acad Sci 1138:214–232PubMed

12.

Creasman WT, DeGeest K, DiSaia PJ, Zaino RJ (1999) Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. Am J Obstet Gynecol 181(1):31–34PubMed

13.

Shepherd JH (1989) Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 96(8):889–892PubMed

14.

Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105(2):103–104PubMed

15.

Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105(2):109PubMed

16.

Dowdy SC, Mariani A (2010) Lymphadenectomy in endometrial cancer: when, not if. Lancet 375(9721):1138–1140PubMed

17.

McMeekin DS, Lashbrook D, Gold M, Scribner DR, Kamelle S, Tillmanns TD et al (2001) Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol 82(2):375–379PubMed

18.

Tozzi R, Malur S, Koehler C, Schneider A (2005) Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy? Gynecol Oncol 97(1):4–9PubMed

19.

Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125–136PubMed

20.

Chan JK, Kapp DS (2007) Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol 8(9):831–841PubMed

21.

Roland PY, Kelly FJ, Kulwicki CY, Blitzer P, Curcio M, Orr JW Jr (2004) The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol Oncol 93(1):125–130PubMed

22.

Benedetti PP, Basile S, Maneschi F, Alberto LA, Signorelli M, Scambia G et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100(23):1707–1716

23.

Kong A, Powell M, Blake P (2008) The role of postoperative radiotherapy in carcinoma of the endometrium. Clin Oncol (R Coll Radiol) 20(6):457–462

24.

Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355(9213):1404–1411PubMed

25.

Johnson N, Cornes P (2007) Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis. BJOG 114(11):1313–1320PubMed

26.

Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375(9717):816–823PubMed

27.

Hardesty LA, Sumkin JH, Nath ME, Edwards RP, Price FV, Chang TS et al (2000) Use of preoperative MR imaging in the management of endometrial carcinoma: cost analysis. Radiology 215(1):45–49PubMed

28.

Hricak H, Stern JL, Fisher MR, Shapeero LG, Winkler ML, Lacey CG (1987) Endometrial carcinoma staging by MR imaging. Radiology 162(2):297–305PubMed

29.

Weber G, Merz E, Bahlmann F, Mitze M, Weikel W, Knapstein PG (1995) Assessment of myometrial infiltration and preoperative staging by transvaginal ultrasound in patients with endometrial carcinoma. Ultrasound Obstet Gynecol 6(5):362–367PubMed

30.

Hardesty LA, Sumkin JH, Hakim C, Johns C, Nath M (2001) The ability of helical CT to preoperatively stage endometrial carcinoma. AJR Am J Roentgenol 176(3):603–606PubMed

31.

Connor JP, Andrews JI, Anderson B, Buller RE (2000) Computed tomography in endometrial carcinoma. Obstet Gynecol 95(5):692–696PubMed

32.

Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB et al (1999) Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212(3):711–718PubMed

33.

Kim SH, Kim HD, Song YS, Kang SB, Lee HP (1995) Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr 19(5):766–772PubMed

34.

Hricak H, Rubinstein LV, Gherman GM, Karstaedt N (1991) MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 179(3):829–832PubMed

35.

Johnson W, Taylor MB, Carrington BM, Bonington SC, Swindell R (2007) The value of hyoscine butylbromide in pelvic MRI. Clin Radiol 62(11):1087–1093PubMed

36.

Frei KA, Kinkel K, Bonel HM, Lu Y, Zaloudek C, Hricak H (2000) Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging—a meta-analysis and Bayesian analysis. Radiology 216(2):444–449PubMed

37.

Barwick TD, Rockall AG, Barton DP, Sohaib SA (2006) Imaging of endometrial adenocarcinoma. Clin Radiol 61(7):545–555PubMed

38.

Scoutt LM, McCarthy SM, Flynn SD, Lange RC, Long F, Smith RC et al (1995) Clinical stage I endometrial carcinoma: pitfalls in preoperative assessment with MR imaging. Work in progress. Radiology 194(2):567–572PubMed

39.

Sironi S, Colombo E, Villa G, Taccagni G, Belloni C, Garancini P et al (1992) Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 185(1):207–212PubMed

40.

Rockall AG, Meroni R, Sohaib SA, Reynolds K, Alexander-Sefre F, Shepherd JH et al (2007) Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 17(1):188–196PubMed

41.

Mariani A, Webb MJ, Keeney GL, Podratz KC (2001) Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 81(1):100–104PubMed

42.

Ascher SM, Reinhold C (2002) Imaging of cancer of the endometrium. Radiol Clin North Am 40(3):563–576PubMed

43.

Seki H, Azumi R, Kimura M, Sakai K (1997) Stromal invasion by carcinoma of the cervix: assessment with dynamic MR imaging. AJR Am J Roentgenol 168(6):1579–1585PubMed

44.

Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF et al (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231(2):372–378PubMed

45.

Toki T, Oka K, Nakayama K, Oguchi O, Fujii S (1998) A comparative study of pre-operative procedures to assess cervical invasion by endometrial carcinoma. Br J Obstet Gynaecol 105(5):512–516PubMed

46.

Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR et al (2005) Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23(12):2813–2821PubMed

47.

Park JY, Kim EN, Kim DY, Suh DS, Kim JH, Kim YM et al (2008) Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 108(3):486–492PubMed

48.

Sohaib SA, Houghton SL, Meroni R, Rockall AG, Blake P, Reznek RH (2007) Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol 62(1):28–34PubMed

49.

Franchi M, La Fianza A, Babilonti L, Bolis PF, Alerci M, Di Giulio G et al (1989) Clinical value of computerized tomography (CT) in assessment of recurrent uterine cancers. Gynecol Oncol 35(1):31–37PubMed

50.

Belhocine T, De Barsy C, Hustinx R, Willems-Foidart J (2002) Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 29(9):1132–1139PubMed

51.

Kitajima K, Suzuki K, Nakamoto Y, Onishi Y, Sakamoto S, Senda M et al (2010) Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence. Eur J Nucl Med Mol Imaging 37(8):1490–1498PubMed

52.

Sigurdsson K (1993) Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991. Int J Cancer 54(4):563–570PubMed

53.

Stanley M (2008) Human papillomavirus vaccines versus cervical cancer screening. Clin Oncol (R Coll Radiol) 20(6):388–394

54.

Pecorelli S, Zigliani L, Odicino F (2009) Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 105(2):107–108PubMed

55.

Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA (1980) Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol 9(1):90–98PubMed

56.

Van NJ Jr, Roddick JW Jr, Lowin DM (1971) The staging of cervical cancer: inevitable discrepancies between clinical staging and pathologic findinges. Am J Obstet Gynecol 110(7):973–978

57.

Hricak H, Powell CB, Yu KK, Washington E, Subak LL, Stern JL et al (1996) Invasive cervical carcinoma: role of MR imaging in pretreatment work-up–cost minimization and diagnostic efficacy analysis. Radiology 198(2):403–409PubMed

58.

Rockall AG, Ghosh S, Alexander-Sefre F, Babar S, Younis MT, Naz S et al (2006) Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA? Gynecol Oncol 101(2):244–249PubMed

59.

Subak LL, Hricak H, Powell CB, Azizi L, Stern JL (1995) Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 86(1):43–50PubMed

60.

Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL (1988) Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 166(3):623–631PubMed

61.

Sahdev A, Sohaib SA, Wenaden AE, Shepherd JH, Reznek RH (2007) The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience. Int J Gynecol Cancer 17(3):629–636PubMed

62.

Kaur H, Silverman PM, Iyer RB, Verschraegen CF, Eifel PJ, Charnsangavej C (2003) Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol 180(6):1621–1631PubMed

63.

Sheu MH, Chang CY, Wang JH, Yen MS (2001) Preoperative staging of cervical carcinoma with MR imaging: a reappraisal of diagnostic accuracy and pitfalls. Eur Radiol 11(9):1828–1833PubMed

64.

Lam WW, So NM, Yang WT, Metreweli C (2000) Detection of parametrial invasion in cervical carcinoma: role of short tau inversion recovery sequence. Clin Radiol 55(9):702–707PubMed

65.

Sironi S, Belloni C, Taccagni GL, DelMaschio A (1991) Carcinoma of the cervix: value of MR imaging in detecting parametrial involvement. AJR Am J Roentgenol 156(4):753–756PubMed

66.

Chung HH, Kang SB, Cho JY, Kim JW, Park NH, Song YS et al (2007) Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer? Jpn J Clin Oncol 37(5):370–375PubMed

67.

Lin WC, Hung YC, Yeh LS, Kao CH, Yen RF, Shen YY (2003) Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 89(1):73–76PubMed

68.

Kaji Y, Sugimura K, Kitao M, Ishida T (1994) Histopathology of uterine cervical carcinoma: diagnostic comparison of endorectal surface coil and standard body coil MRI. J Comput Assist Tomogr 18(5):785–792PubMed

69.

Hricak H, Yu KK (1996) Radiology in invasive cervical cancer. AJR Am J Roentgenol 167(5):1101–1108PubMed

70.

Taylor MB, Carrington BM, Davidson SE, Swindell R, Lawrance JA (2003) Staging of advanced cervical carcinoma using MRI-predictors of outcome after radical radiotherapy. Clin Radiol 58(7):532–541PubMed

71.

Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J (2003) Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91(1):59–66PubMed

72.

Kim SH, Choi BI, Han JK, Kim HD, Lee HP, Kang SB et al (1993) Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr 17(4):633–640PubMed

73.

Cobby M, Browning J, Jones A, Whipp E, Goddard P (1990) Magnetic resonance imaging, computed tomography and endosonography in the local staging of carcinoma of the cervix. Br J Radiol 63(753):673–679PubMed

74.

Kim SH, Choi BI, Lee HP, Kang SB, Choi YM, Han MC et al (1990) Uterine cervical carcinoma: comparison of CT and MR findings. Radiology 175(1):45–51PubMed

75.

Hricak H, Gatsonis C, Coakley FV, Snyder B, Reinhold C, Schwartz LH et al (2007) Early invasive cervical cancer: CT and MR imaging in preoperative evaluation—ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology 245(2):491–498PubMed

76.

Shepherd JH, Crawford RA, Oram DH (1998) Radical trachelectomy: a way to preserve fertility in the treatment of early cervical cancer. Br J Obstet Gynaecol 105(8):912–916PubMed

77.

Peppercorn PD, Jeyarajah AR, Woolas R, Shepherd JH, Oram DH, Jacobs IJ et al (1999) Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experience. Radiology 212(2):395–399PubMed

78.

Narayan K, McKenzie AF, Hicks RJ, Fisher R, Bernshaw D, Bau S (2003) Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. Int J Gynecol Cancer 13(5):657–663PubMed

79.

Mitchell DG, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola MA et al (2009) Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study. Gynecol Oncol 112(1):95–103PubMedPubMedCentral

80.

Aoki Y, Sasaki M, Watanabe M, Sato T, Tsuneki I, Aida H et al (2000) High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol 77(2):305–309PubMed

81.

Odunsi KO, Lele S, Ghamande S, Seago P, Driscoll DL (2001) The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer. Eur J Gynaecol Oncol 22(5):325–330PubMed

82.

Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ (1996) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol 167(6):1503–1507PubMed

83.

Barentsz JO, Jager GJ, van Vierzen PB, Witjes JA, Strijk SP, Peters H et al (1996) Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 201(1):185–193PubMed

84.

Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C (2000) Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol 175(3):759–766PubMed

85.

Hancke K, Heilmann V, Straka P, Kreienberg R, Kurzeder C (2008) Pretreatment staging of cervical cancer: is imaging better than palpation?: Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients. Ann Surg Oncol 15(10):2856–2861PubMed

86.

Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F (1999) Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 17(1):41–45PubMed

87.

Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl RL (1999) Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 40(7):1125–1131PubMed

88.

Loft A, Berthelsen AK, Roed H, Ottosen C, Lundvall L, Knudsen J et al (2007) The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 106(1):29–34PubMed

89.

Magne N, Chargari C, Vicenzi L, Gillion N, Messai T, Magne J et al (2008) New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET. Cancer Treat Rev 34(8):671–681PubMed

90.

Chao A, Ho KC, Wang CC, Cheng HH, Lin G, Yen TC et al (2008) Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases. Gynecol Oncol 110(2):172–178PubMed

91.

Park W, Park YJ, Huh SJ, Kim BG, Bae DS, Lee J et al (2005) The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer. Jpn J Clin Oncol 35(5):260–264PubMed

92.

Chou HH, Chang TC, Yen TC, Ng KK, Hsueh S, Ma SY et al (2006) Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol 24(1):123–128PubMed

93.

Sironi S, Buda A, Picchio M, Perego P, Moreni R, Pellegrino A et al (2006) Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 238(1):272–279PubMed

94.

Wright JD, Dehdashti F, Herzog TJ, Mutch DG, Huettner PC, Rader JS et al (2005) Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer 104(11):2484–2491PubMed

95.

Grigsby PW, Siegel BA, Dehdashti F (2001) Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19(17):3745–3749PubMed

96.

Cannistra SA, Niloff JM (1996) Cancer of the uterine cervix. N Engl J Med 334(16):1030–1038PubMed

97.

Halpin TF, Frick HC, Munnell EW (1972) Critical points of failure in the therapy of cancer of the cervix: a reappraisal. Am J Obstet Gynecol 114(6):755–764PubMed

98.

Shepherd JH, Ngan HY, Neven P, Fryatt I, Woodhouse CR, Hendry WF (1994) Multivariate analysis of factors affecting survival in pelvic exenteration. Int J Gynecol Cancer 4(6):361–370PubMed

99.

Babar S, Rockall A, Goode A, Shepherd J, Reznek R (2007) Magnetic resonance imaging appearances of recurrent cervical carcinoma. Int J Gynecol Cancer 17(3):637–645PubMed

100.

Popovich MJ, Hricak H, Sugimura K, Stern JL (1993) The role of MR imaging in determining surgical eligibility for pelvic exenteration. AJR Am J Roentgenol 160(3):525–531PubMed

101.

Kinkel K, Ariche M, Tardivon AA, Spatz A, Castaigne D, Lhomme C et al (1997) Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology 204(1):55–63PubMed

102.

Chung HH, Jo H, Kang WJ, Kim JW, Park NH, Song YS et al (2007) Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence. Gynecol Oncol 104(3):529–534PubMed

103.

Sironi S, Picchio M, Landoni C, Galimberti S, Signorelli M, Bettinardi V et al (2007) Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence. Eur J Nucl Med Mol Imaging 34(4):472–479PubMed

104.

Narayanan P, Nobbenhuis M, Reynolds KM, Sahdev A, Reznek RH, Rockall AG (2009) Fistulas in malignant gynecologic disease: etiology, imaging, and management. Radiographics 29(4):1073–1083PubMed

105.

Emmert C, Kohler U (1996) Management of genital fistulas in patients with cervical cancer. Arch Gynecol Obstet 259(1):19–24PubMed

106.

Healy JC, Phillips RR, Reznek RH, Crawford RA, Armstrong P, Shepherd JH (1996) The MR appearance of vaginal fistulas. AJR Am J Roentgenol 167(6):1487–1489PubMed

107.

Sahdev A, Jones J, Shepherd JH, Reznek RH (2005) MR imaging appearances of the female pelvis after trachelectomy. Radiographics 25(1):41–52PubMed

108.

Shepherd JH, Milliken DA (2008) Conservative surgery for carcinoma of the cervix. Clin Oncol (R Coll Radiol) 20(6):395–400

Title: Imaging of endometrial and cervical cancer
Authors: Shilpa Patel
Sidath H. Liyanage
Anju Sahdev
Andrea G. Rockall
Rodney H. Reznek
Publication date: 01-11-2010
Publisher: Springer Berlin Heidelberg
Published in: Insights into Imaging / Issue 5-6/2010
Electronic ISSN: 1869-4101
DOI: https://doi.org/10.1007/s13244-010-0042-7

At a glance: The STEP trials

Springer Medicine

Imaging of endometrial and cervical cancer

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5-6/2010

Uncharted waters: rare and unclassified cardiomyopathies characterized on cardiac magnetic resonance imaging

Technical aspects of CT imaging of the spine

Imaging of pancreas transplantation and its complications

Pancreatic transplantation: surgical technique, normal radiological appearances and complications

Imaging with non-FDG PET tracers: outlook for current clinical applications

Imaging for suspected pulmonary embolism in pregnancy—what about the fetal dose? A comprehensive review of the literature